神经调节蛋白-1改善实验性心肌梗死大鼠心脏葡萄糖代谢
该研究在大鼠心肌梗死模型中给予重组人NRG-1β干预6周,发现NRG-1可提高LVEF和LVFS、增加心肌葡萄糖摄取与ATP生成、减少胶原沉积和心肌细胞凋亡及ROS生成,并上调Glut-4、HK2、PDH、CS表达、下调PDK4。
要点
- NRG-1β干预6周可改善MI大鼠左心室收缩功能。
- NRG-1β提高梗死心肌葡萄糖摄取、PDH和CS活性及ATP生成。
- NRG-1β减少胶原面积分数、心肌细胞凋亡和ROS生成。
核心结论
- NRG-1通过激活心肌ErbB4受体磷酸化,促进MI大鼠心肌葡萄糖摄取和利用,为改善梗死后能量代谢提供干预靶点。
研究设计与样本
- 成年雄性SD大鼠随机分为假手术组、心肌梗死组和心肌梗死+NRG-1组,每组6只。
- 通过结扎冠状动脉左前降支建立MI模型,术后2周选取LVEF 0.3-0.5的MI大鼠随机分入MI组和MI+NRG-1组。
- MI+NRG-1组于术后2周经尾静脉注射重组人NRG-1β 100 μg/kg,每周2次共6周;假手术组和MI组给予等量生理盐水。
- 干预结束后行超声心动图和小动物PET检测心脏功能与心肌葡萄糖摄取,并行组织病理学、试剂盒、qRT-PCR和Western blot检测。
主要发现
- 建模成功后MI组和MI+NRG-1组LVEF及LVFS均低于假手术组(P均<0.01),两组间差异无统计学意义(P均>0.05)。
- NRG-1β干预6周后MI+NRG-1组LVEF及LVFS高于MI组(P均<0.01)。
- PET示SUVmean在MI+NRG-1组低于假手术组(4.06±0.28比5.18±0.37,P<0.01),但高于MI组(4.06±0.28比2.86±0.49,P<0.01)。
- MI+NRG-1组左心室胶原面积分数低于MI组((7.83±1.24)%比(18.31±3.58)%,P<0.01),心肌细胞凋亡比例低于MI组((37.98±4.26)%比(67.04±5.38)%,P<0.01),DHE荧光强度低于MI组(0.057 28±0.007 06比0.076 94±0.008 46,P<0.01)。
- MI+NRG-1组PDH活性及CS活性高于MI组(P均<0.05),ATP生成更多(P<0.01);Glut-4、HK2和CS mRNA上调而PDK4 mRNA下调(P均<0.01);NRG-1、p-ErbB4、Glut-4、HK2、PDH和CS蛋白表达高于MI组(P均<0.01)。
临床怎么用
- NRG-1/ErbB4通路可能作为改善心肌梗死后能量代谢的干预靶点,但当前仅为大鼠实验证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the effect of neuregulin-1(NRG-1) on cardiac glucose metabolism in Sprague Dawley (SD) rats with experimental myocardial infarction (MI). Methods: Adult male SD rats were randomly divided into three groups: the sham-operated group, MI group, and MI+NRG1 group. The rat MI model was established via ligation of the left anterior descending coronary artery. Two weeks after operation, echocardiography was performed, MI rats with left ventricular ejection fraction (LVEF) between 0.3-0.5 were selected and randomly assigned to MI group and MI+NRG-1 group. Rats in MI+NRG-1 group were treated with recombinant human NRG-1β (100 μg/kg) via tail vein at 2 weeks after operation (twice per week for 6 weeks); while rats in sham-operated group and MI group received equal volume of physiological saline. By the end of administration, echocardiography and small animal positron emission tomography (PET) were performed to detect cardiac function and myocardial glucose uptake. Myocardial morphology and collagen volume fraction, cardiomyocyte apoptosis and reactive oxygen species (ROS) production were evaluated by histopathologic analysis. Myocardial pyruvate dehydrogenase (PDH) and citrate synthase (CS) activity, as well as ATP production were detected by commercial kits. The mRNA and protein expression levels of NRG-1, p-ErbB4, and key factors involved in glucose metabolism (including Glut-4, HK2, PDK4, PDH, CS) were detected by quantitative real-time PCR (qRT-PCR) and Western blot assay, respectively. Results: With the MI model successfully established, the left ventricular ejection fraction(LVEF) and left ventricular shortening fraction(LVFS) were significantly lower in MI group and MI+NRG-1 group than that in sham group (both P<0.01), while there was no significant difference between MI group and MI+NRG-1 group(all P>0.05). After 6 weeks of NRG-1β intervention, the LVEF and LVFS were significantly higher in MI+NRG-1 group than in MI group (both P<0.01). By the end of experiment, PET imaging showed that the mean standardized uptake value (SUVmean) were lower in MI+NRG-1 group than in the sham group (4.06±0.28 vs. 5.18±0.37, P<0.01), while significantly higher than that in MI group (4.06±0.28 vs.2.86±0.49, P<0.01). Histopathological analysis showed that compared with MI group, rats in MI+NRG-1 group exhibited significantly decreased left ventricle collagen volume fraction ((7.83±1.24) % vs. (18.31±3.58) %, P<0.01), cardiomyocyte apoptosis((37.98±4.26)% vs. (67.04±5.38)%, P<0.01), and DHE fluorescence intensity(0.057 28±0.007 06 vs. 0.076 94±0.008 46, P<0.01), indicating that NRG-1β could reduce ROS production. PDH activity, CS activity, and ATP production were significantly higher in MI+NRG-1 group than in MI group (all P<0.05). qRT-PCR demonstrated an upregulated Glut-4, HK2 and CS, but downregulated PDK4 mRNA expression in MI+NRG-1 group compared with MI group (all P<0.01). Western blot assay showed significantly higher protein expression of NRG-1, p-ErbB4, Glut-4, HK2, PDH, CS in MI+NRG-1 group than in MI group (all P<0.01). Conclusion: NRG-1 could improve glucose uptake and utilization in myocardium by activating phosphorylation of myocardial ErbB4 receptor in MI rats, thus providing a therapeutic option for improving energy metabolism after MI. 目的: 探讨神经调节蛋白-1(NRG-1)对SD大鼠心肌梗死后心脏葡萄糖代谢的改善作用。 方法: 成年雄性SD大鼠随机分为3组:假手术组、心肌梗死组和心肌梗死+NRG-1组,每组6只。通过结扎冠状动脉左前降支建立心肌梗死模型,心肌梗死+NRG-1组大鼠在建模成功后,于尾静脉注射NRG-1β(100 μg/kg),每周2次,共6周;假手术组和心肌梗死组则给予等量生理盐水注射。干预结束后,予超声心动图及小动物正电子发射断层扫描(PET)检测心脏功能和心肌葡萄糖摄取。组织病理学染色观察心肌纤维形态和胶原面积分数,检测心肌细胞凋亡和细胞内活性氧(ROS)水平。商品化试剂盒检测组织丙酮酸脱氢酶(PDH)、柠檬酸合成酶(CS)活性以及ATP生成浓度。实时荧光定量PCR(qRT-PCR)检测组织葡萄糖转运子-4(Glut-4)、己糖激酶-2(HK2)、丙酮酸脱氢酶激酶-4(PDK4)、CS mRNA表达水平;Western blot检测NRG-1、磷酸化酪氨酸激酶受体-4(p-ErbB4)及葡萄糖代谢相关蛋白(包括Glut-4、HK2、PDH、CS)表达水平。 结果: 建模成功后,心肌梗死组和心肌梗死+NRG-1组大鼠的左心室射血分数(LVEF)和左心室短轴缩短分数(LVFS)低于假手术组(P均<0.01),两组的各项参数差异均无统计学意义(P均>0.05);给予NRG-1β干预6周后,心肌梗死+NRG-1组的LVEF及LVFS较心肌梗死组高(P均<0.01)。PET检查结果显示,干预结束后,心肌梗死+NRG-1组大鼠的标准化摄取值平均值(SUVmean)低于假手术组(4.06±0.28比5.18±0.37,P<0.01),但明显高于心肌梗死组(4.06±0.28比2.86±0.49,P<0.01)。病理染色结果显示,心肌梗死+NRG-1组的左心室胶原面积分数[(7.83±1.24)%比(18.31±3.58)%,P<0.01]、心肌细胞凋亡比例[(37.98±4.26)%比(67.04±5.38)%,P<0.01]明显低于心肌梗死组,DHE染色荧光强度低于心肌梗死组(0.057 28±0.007 06比0.076 94±0.008 46,P<0.01),提示NRG-1β干预可减少ROS生成。心肌梗死+NRG-1组心肌组织的PDH活性及CS活性较心肌梗死组高(P均<0.05),ATP生成亦更多(P<0.01)。qRT-PCR结果显示,与心肌梗死组比较,心肌梗死+NRG-1组大鼠心肌组织Glut-4、HK2和CS mRNA表达水平上调,而PDK4 mRNA表达水平下调(P均<0.01)。Western blot检测结果显示,心肌梗死+NRG-1组的NRG-1和p-ErbB4蛋白表达水平高于心肌梗死组,同时Glut-4、HK2、PDH和CS蛋白表达水平亦较心肌梗死组上调(P均<0.01)。 结论: NRG-1通过激活心肌组织ErbB4受体的磷酸化表达,促进梗死后心肌组织的葡萄糖摄取和利用,为改善心肌梗死后能量代谢提供了干预靶点。.
引用
- Wang JF, Li FH, Shen DL, et al. [Effect of neuregulin-1 on cardiac glucose metabolism in rats with experimental myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi. 2021. PMID: 34530600. doi:10.3760/cma.j.cn112148-20210628-00549
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。